TripleMed Archives - Vascular News

Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols...

8th June 2021

TripleMed BV recently announced an enrolment update regarding the pivotal clinical study of the company’s AneuFix product for the treatment of type II endoleaks. According...

Write to us
Editor: Jocelyn Hudson [email protected]
Advertising: Rav Pankhania [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: TripleMed

Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols...